Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K0LA
|
||||
| Former ID |
DIB000547
|
||||
| Drug Name |
LC34AD3
|
||||
| Synonyms |
LC34AD3; GPR119 agonists (type 2 diabetes); GPR119 agonists (type 2 diabetes), LG Life Sciences; G-protein coupled receptor 119 agonist (type 2 diabetes), LG Life Sciences
|
||||
| Indication | Non-insulin dependent diabetes [ICD10:E11.9] | Investigative | [543393] | ||
| Company |
LG Life Sciences Ltd
|
||||
| Target and Pathway | |||||
| Target(s) | Glucose-dependent insulinotropic receptor | Target Info | Agonist | [543393] | |
| KEGG Pathway | cAMP signaling pathway | ||||
| Insulin secretion | |||||
| WikiPathways | Incretin Synthesis, Secretion, and Inactivation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.